MARIMED INC. — Earnings
Most recent reported period: FY2026 (Q1) (filed for period ending 2026-03-31) · sourced from SEC EDGAR
Next earnings (estimated): Tue, June 30, 2026 — ~44 days away. Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2026-03-31 | $39M | ↑+4.2% | $-4M | ↑+31.3% | 0.3% |
| 2025-12-31 | $42M | ↑+7.5% | — | — | — |
| 2025-09-30 | $41M | ↑+0.4% | $-3M | ↓-193.0% | 3.9% |
| 2025-06-30 | $40M | ↓-2.0% | $-1M | ↑+21.6% | 2.9% |
| 2025-03-31 | $38M | ↓-0.1% | $-6M | ↓-294.5% | -2.4% |
| 2024-12-31 | $39M | ↓-0.4% | — | — | — |
| 2024-09-30 | $41M | ↑+4.6% | $-1M | ↑+76.4% | 3.3% |
| 2024-06-30 | $40M | ↑+10.7% | $-2M | ↓-90.3% | 2.4% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2026 (Q1)
Revenue
$39M
↑+4.2% +$2M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 61 quarters
margin trajectory tells the operating-leverage storyGross Margin↓-1.1pts
38.7%
Operating Margin↑+2.7pts
0.3%
Net Margin↑+5.0pts
-9.6%
Go deeper
MRMD Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyMRMD Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics